Viewing Study NCT03387332


Ignite Creation Date: 2025-12-24 @ 9:23 PM
Ignite Modification Date: 2026-04-10 @ 9:54 PM
Study NCT ID: NCT03387332
Status: TERMINATED
Last Update Posted: 2021-08-27
First Post: 2017-12-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: APG-1252 in Patients With SCLC or Advanced Solid Tumors
Sponsor: Ascentage Pharma Group Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module